Victory Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,564
| Closed | -$573K | – | 2604 |
|
|
2023
Q2 | $573K | Sell |
14,564
-340
| -2% | -$12K | ﹤0.01% | 1924 |
|
|
2023
Q1 | $363K | Buy |
14,904
+296
| +2% | +$6.48K | ﹤0.01% | 2091 |
|
|
2022
Q4 | $313K | Sell |
14,608
-15,404
| -51% | -$329K | ﹤0.01% | 2160 |
|
|
2022
Q3 | $538K | Sell |
30,012
-14,942
| -33% | -$196K | ﹤0.01% | 2021 |
|
|
2022
Q2 | $432K | Buy |
44,954
+3,517
| +8% | +$44.1K | ﹤0.01% | 2122 |
|
|
2022
Q1 | $574K | Buy |
41,437
+14,115
| +52% | +$209K | ﹤0.01% | 2071 |
|
|
2021
Q4 | $457K | Buy |
27,322
+13,593
| +99% | +$223K | ﹤0.01% | 2198 |
|
|
2021
Q3 | $223K | Buy |
13,729
+2,209
| +19% | +$24K | ﹤0.01% | 2485 |
|
|
2021
Q2 | $73K | Sell |
11,520
-1,221
| -10% | -$7.88K | ﹤0.01% | 2636 |
|
|
2021
Q1 | $79K | Sell |
12,741
-463
| -4% | -$2.81K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $91K | Sell |
13,204
-28
| -0.2% | -$179 | ﹤0.01% | 2423 |
|
|
2020
Q3 | $75K | Buy |
13,232
+1,006
| +8% | +$4.8K | ﹤0.01% | 2364 |
|
|
2020
Q2 | $62K | Sell |
12,226
-856
| -7% | -$3.57K | ﹤0.01% | 2387 |
|
|
2020
Q1 | $46K | Buy |
+13,082
| New | +$76.5K | ﹤0.01% | 2818 |
|
|
2019
Q4 | – | Sell |
-5,960
| Closed | -$7K | – | 3471 |
|
|
2019
Q3 | $7K | Buy |
+5,960
| New | +$6.93K | ﹤0.01% | 3378 |
|
Victory Capital Management's ISEE Position: Q3 2023 in Review
Victory Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 14,564 shares — an estimated $573K sold.
Victory Capital Management first reported a position in ISEE in Q3 2019 and held it in 15 quarters. The position peaked at $574K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Victory Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Victory Capital Management sold 14,564 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $573K.
- Victory Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2019 and held it in 15 quarters.
- Victory Capital Management's IVERIC bio, Inc. Common Stock position peaked at $574K in Q1 2022.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.